Skip to main content

Table 3 Concomitant therapy in patients over the follow-up period

From: Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational study

  Follow-up time (months) Yes No
Treatment   N % N %
VDRA 6 261 46 307 54.0
12 328 57.8 239 42.2
18 335 67.5 161 32.5
24 254 74.1 89 25.9
30 162 75.7 52 24.3
36 99 77.3 29 22.7
Non-calcium-based phosphate binders 6 223 39.3 345 60.7
12 300 52.9 267 47.1
18 296 59.7 200 40.3
24 222 64.7 121 35.3
30 147 68.7 67 31.3
36 90 70.3 38 29.7
Calcium-based phosphate binders 6 302 53.2 266 46.8
12 354 62.4 213 37.6
18 339 68.3 157 31.7
24 250 72.9 93 27.1
30 161 75.2 53 24.8
36 97 75.8 31 24.2